Catalyst Pharmaceuticals, Inc. (CPRX) Ownership

$24.49

$0.38 (1.58%)
Last update: 04:00 PM EST
Day's range
$23.76
Day's range
$24.55

Catalyst Pharmaceuticals, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 05/02/2025 18.80 M $456.01 M   -3.20% 15.48%
VANGUARD GROUP INC 05/09/2025 8.50 M $206.02 M   0.76% 6.99%
STATE STREET CORP 05/15/2025 5.53 M $134.11 M   -4.59% 4.55%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 05/15/2025 3.42 M $82.99 M   9.23% 2.82%
GOLDMAN SACHS GROUP INC 05/16/2025 3.14 M $76.04 M   11.89% 2.58%
RENAISSANCE TECHNOLOGIES LLC 05/14/2025 2.96 M $71.69 M   9.25% 2.43%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 2.77 M $67.08 M   3.75% 2.28%
MORGAN STANLEY 05/15/2025 2.39 M $58.07 M   14.68% 1.97%
DIMENSIONAL FUND ADVISORS LP 05/13/2025 2.19 M $53.05 M   -27.40% 1.80%
FUNDSMITH LLP 05/15/2025 2.15 M $52.17 M   100.00% 1.77%
BANK OF AMERICA CORP /DE/ 05/15/2025 1.81 M $43.93 M   15.47% 1.49%
ROYCE & ASSOCIATES LP 05/06/2025 1.60 M $38.76 M   -14.27% 1.32%
NORTHERN TRUST CORP 05/13/2025 1.49 M $36.04 M   -1.16% 1.22%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 1.33 M $32.17 M   6.40% 1.09%
BOSTON PARTNERS 05/13/2025 1.28 M $30.63 M   -1.28% 1.05%
INVESCO LTD. 05/12/2025 1.20 M $29.09 M   41.66% 0.99%
KENNEDY CAPITAL MANAGEMENT LLC 05/13/2025 1.06 M $25.74 M   4.29% 0.87%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 05/14/2025 1.04 M $25.10 M   48.25% 0.85%
PRICE T ROWE ASSOCIATES INC /MD/ 05/14/2025 977.62 K $23.71 M   -19.57% 0.80%
MACQUARIE GROUP LTD 05/15/2025 934.93 K $22.66 M   36.95% 0.77%
PACER ADVISORS, INC. 05/06/2025 854.37 K $20.72 M   -71.09% 0.70%
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) 05/07/2025 786.90 K $19.08 M   7.51% 0.65%
05/12/2025 768.01 K $17.19 M   100.00% 0.63%
ABRDN PLC 05/13/2025 765.29 K $18.56 M   57.90% 0.63%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2025 760.30 K $18.44 M   15.33% 0.63%
METLIFE INVESTMENT MANAGEMENT, LLC 05/14/2025 724.09 K $17.56 M   963.48% 0.60%
BANK OF NEW YORK MELLON CORP 04/29/2025 709.93 K $17.22 M   -1.88% 0.58%
LSV ASSET MANAGEMENT 05/09/2025 703.80 K $17.07 M   -9.44% 0.58%
ALLIANZ ASSET MANAGEMENT GMBH 05/05/2025 694.13 K $16.83 M   397.76% 0.57%
CITADEL ADVISORS LLC 05/15/2025 685.42 K $16.62 M   57.04% 0.56%
PRINCIPAL FINANCIAL GROUP INC 04/28/2025 617.51 K $14.97 M   2.83% 0.51%
LEGAL & GENERAL GROUP PLC 05/15/2025 573.64 K $13.91 M   66.45% 0.47%
VICTORY CAPITAL MANAGEMENT INC 05/02/2025 539.78 K $13.09 M   82.31% 0.44%
AMERICAN CENTURY COMPANIES INC 05/13/2025 526.57 K $12.77 M   234.52% 0.43%
UBS ASSET MANAGEMENT AMERICAS INC 05/19/2025 526.30 K $12.76 M   99.43% 0.43%
JACOBS LEVY EQUITY MANAGEMENT, INC 05/15/2025 506.45 K $12.28 M   -44.53% 0.42%
JUPITER ASSET MANAGEMENT LTD 05/09/2025 488.59 K $11.85 M   1.37% 0.40%
OBERWEIS ASSET MANAGEMENT INC/ 05/15/2025 467.60 K $11.34 M   0.11% 0.38%
AQR CAPITAL MANAGEMENT LLC 05/15/2025 445.51 K $10.80 M   -6.60% 0.37%
RAYMOND JAMES FINANCIAL INC 05/13/2025 440.52 K $10.68 M   33.50% 0.36%
GABLES CAPITAL MANAGEMENT INC. 05/08/2025 416.37 K $10.10 M   -0.28% 0.34%
JW ASSET MANAGEMENT, LLC 05/09/2025 413.39 K $10.02 M   0.00% 0.34%
PUBLIC SECTOR PENSION INVESTMENT BOARD 05/12/2025 410.76 K $9.96 M   46.97% 0.34%
PRUDENTIAL FINANCIAL INC 05/13/2025 381.18 K $9.24 M   -31.12% 0.31%
JPMORGAN CHASE & CO 05/12/2025 352.53 K $8.55 M   -52.11% 0.29%
NEW VERNON CAPITAL HOLDINGS II LLC 05/15/2025 327.86 K $13.52 M   5,531.40% 0.27%
FMR LLC 05/12/2025 319.88 K $7.76 M   184.38% 0.26%
JANUS HENDERSON GROUP PLC 05/15/2025 319.83 K $7.90 M   -32.81% 0.26%
RHUMBLINE ADVISERS 04/08/2025 310.57 K $7.53 M   -0.56% 0.26%
MILLENNIUM MANAGEMENT LLC 05/15/2025 303.53 K $7.36 M   -41.72% 0.25%

Catalyst Pharmaceuticals, Inc. institutional Ownership - FAQ's

During the previous two years, 434 institutional investors and hedge funds held shares of Catalyst Pharmaceuticals, Inc.. The most heavily invested institutionals were:

BlackRock, Inc.: 18.8 M

VANGUARD GROUP INC: 8.5 M

STATE STREET CORP: 5.53 M

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 3.42 M

GOLDMAN SACHS GROUP INC: 3.14 M

RENAISSANCE TECHNOLOGIES LLC: 2.96 M

80.20% of Catalyst Pharmaceuticals, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 119.58 M shares in the last 24 months. This purchase volume represents approximately $2.93 B in transactions.